Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,284 | -6,784 | -5,129 | -3,873 | -4,004 |
| Depreciation Amortization | 9 | 13 | 4 | 3 | 6 |
| Accounts receivable | 7,625 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 347 | N/A | 212 | 167 | N/A |
| Other Working Capital | 7,715 | 389 | 412 | 268 | -69 |
| Other Operating Activity | -7,849 | 2,013 | 1,761 | 1,778 | 239 |
| Operating Cash Flow | $5,563 | $-4,369 | $-2,740 | $-1,657 | $-3,828 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -153 | 0 | N/A | N/A | 0 |
| Investing Cash Flow | $-153 | $0 | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2,500 | 2,500 | N/A |
| Common Stock Issued | 1,646 | N/A | 4 | 4 | N/A |
| Other Financing Activity | 55,900 | 11,524 | 4,467 | 4,500 | 4,000 |
| Financing Cash Flow | $57,546 | $11,524 | $6,971 | $7,004 | $4,000 |
| Beginning Cash Position | 7,813 | 658 | 658 | 658 | 486 |
| End Cash Position | 70,769 | 7,813 | 4,889 | 6,005 | 658 |
| Net Cash Flow | $62,956 | $7,155 | $4,231 | $5,347 | $172 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,563 | -4,369 | -2,740 | -1,657 | -3,828 |
| Capital Expenditure | -153 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 5,410 | -4,369 | -2,740 | -1,657 | -3,828 |